Article
HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix.
International journal of radiation oncology, biology, physics - 15 Nov 2012
Wang Chun-Chieh, Lai Chyong-Huey, Huang Yi-Ting, Chao Angel, Chou Hung-Hsueh, Hong Ji-Hong
Abstract excerpt
PURPOSE: To study the prognostic value of human papillomavirus (HPV) genotypes in patients with advanced cervical cancer treated with radiation therapy (RT) alone or concurrent chemoradiation therapy (CCRT). METHODS AND MATERIALS: Between August 1993 and May 2000, 327 patients with advanced squamous cell carcinoma of the cervix (International Federation of Gynecology and Obstetrics stage III/IVA or stage IIB with...
Topics
- Adult
- Aged
- Analysis of Variance
- Antineoplastic Agents
- Carcinoma, Squamous Cell
- Chemoradiotherapy
- Cisplatin
- Disease-Free Survival
- Female
- Fluorouracil
